Biographica Ltd

Biographica Ltd, based in the UK, is focused on advancing agricultural biotechnology through genetically edited crops, addressing global food security challenges using innovative machine learning and high-throughput sequencing techniques. Founded in 2022 in London, UK, Biographica Ltd specializes in agricultural biotechnology, providing a predictive discovery platform for gene-editing. The company has engaged in 2 distinct investment deals and has successfully raised GBP 7. 000 mn through its latest SEED funding round led by Faber Ventures, with participation from investors including Cardumen Capital, Chalfen Ventures, Entrepreneur First, SuperSeed, and The Helm.

Biographica specializes in accelerating the development of genetically edited crops to tackle global food security issues. The company employs advanced machine learning and high-throughput sequencing to identify genetic targets for gene-editing. Their primary offering is a predictive discovery platform that assists agricultural biotechnology firms in optimizing genetic edits to improve crop traits like productivity, sustainability, and climate resilience, serving clients in North America, Europe, and parts of Asia. Biographica generates revenue through partnerships with agricultural biotechnology firms, offering subscription-based access to their predictive discovery platform and related services.

The company engages in business-to-business transactions, providing tailored insights and genetic target identification to enhance client offerings. While specific pricing structures are not disclosed, they are customized according to the complexities of the projects undertaken by clients. Biographica Ltd plans to leverage its recent SEED funding of GBP 7. 000 mn to enhance its predictive discovery platform and explore new product developments aimed at improving genetic editing for crop traits.

The company is targeting expansion into additional markets across Asia and Europe by the end of 2024, aiming to establish partnerships with local agricultural firms. Recent funding will facilitate these initiatives, supporting the development of innovative solutions in the agricultural biotechnology sector.